Home > Insider Trading > Filing (0001209191-15-008391)

Filing Details

Accession Number:: 0001209191-15-008391
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-02-02 18:06:18
Reporting Period:: 2015-01-30

Filing Date:: 2015-02-02
Accepted Time:: 2015-02-02 18:06:18
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1175609	Cavium Inc.	CAVM	Semiconductors & Related Devices (3674)	770558625

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1397903	Kumar Anil Jain	C/O Cavium, Inc. 2315 N. First Street San Jose CA 95131	Corporate Vp, Ic Engineering	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2015-01-30	36,144	$36.57	91,719	No	4	M	Direct
Common Stock	Disposition	2015-01-30	36,144	$59.81	55,575	No	4	S	Direct
Common Stock	Acquisiton	2015-01-30	5,625	$0.00	61,200	No	4	M	Direct
Common Stock	Acquisiton	2015-01-31	7,282	$0.00	68,482	No	4	A	Direct
Common Stock	Acquisiton	2015-02-02	3,706	$36.93	72,188	No	4	A	Direct
Common Stock	Disposition	2015-02-02	8,000	$57.08	64,188	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	A	Direct
No	4	A	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock option right to buy	Disposition	2015-01-30	36,144	$0.00	36,144	$36.57
Common Stock	Restricted stock units	Disposition	2015-01-30	2,625	$0.00	2,625	$0.00
Common Stock	Restricted stock units	Disposition	2015-01-30	3,000	$0.00	3,000	$0.00
Common Stock	Stock option right to buy	Disposition	2015-02-02	3,706	$0.00	3,706	$36.93

Remaning Holdings	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
32,856	No	4	M	Direct
0	No	4	M	Direct
3,000	No	4	M	Direct
29,150	No	4	M	Direct

Footnotes

The exercise price of the options ranges from $35.73 to $37.83 per share.
Also include common stock underlying restricted stock units previously reported on Table 1 but not yet vested. These unvested shares were not previously reported in column 5 in prior Form 4 filings.
The sale was made under a 10b5-1 trading plan adopted by the reporting person.
Shares were sold ranging from $58.58 per share to $61.53 per share.
As reported on Form 4 dated on March 14, 2011, the reporting person received a grant of 10,500 Restricted Stock Units ("RSU's") on March 10, 2011 pursuant to Cavium's 2007 Equity Incentive Plan. 25% of the RSUs will vest annually on each of January 30, 2012, January 30, 2013, January 30, 2014 and January 30, 2015. On each vesting date, for each RSU vesting on such date, the reporting person will receive one share of Cavium's common stock at no cost. On January 30, 2015, the final 25% of these RSU's vested, resulting in the issuance of 2,625 shares of Cavium's common stock.
As reported on Form 4 dated February 28, 2012, the reporting person received a grant of 12,000 Restricted Stock Units ("RSU's") on February 24, 2012 pursuant to Cavium's 2007 Equity Incentive Plan. 25% of the RSUs will vest annually on each of January 30, 2013, January 30, 2014, January 30, 2015 and January 30, 2016. On each vesting date, for each RSU vesting on such date, the reporting person will receive one share of Cavium's common stock at no cost. On January 30, 2015, the third 25% of these RSU's vested, resulting in the issuance of 3,000 shares of Cavium's common stock.
On February 7, 2014, Cavium's Compensation Committee granted performance RSUs of up to 8,800 shares to the reporting person based on the achievement of a certain milestone. Any performance RSUs earned upon achievement of the certain milestone will vest and the underlying common stock will be issued to the reporting person on January 31, 2015. As determined by Cavium's Compensation Committee on January 29, 2015, the performance criteria were met at a level that caused 7,282 shares to vest, and the reporting person received 7,282 shares of Cavium's common stock at no cost.
Shares were sold ranging from $55.65 per share to $58.03 per share.
The exercisable date ranges from 9/10/2011 to 8/7/2014 (1/8th of the option vest on six month anniversary of the vesting commencement date and 1/48th of the shares vest monthly thereafter over the next three and one half years). The expiration date ranges from 1/6/2017 to 2/7/2021.